Quantitative serum proteomics from surface plasmon resonance imaging

Molecular and Cellular Proteomics

Volumn 7, Issue 12, 2008, Pages 2464-2474

  Lausted, Christopher ^a   Hu, Zhiyuan ^a   Hood, Leroy ^a  

^a INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; PROTEIN ANTIBODY; TRANSFERRIN; TUMOR MARKER;

ARTICLE; CALIBRATION; CASE REPORT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIVER CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEOMICS; QUANTITATIVE ANALYSIS; SERUM; SURFACE PLASMON RESONANCE; VALIDATION PROCESS;

MURINAE;

EID: 58149295602     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M800121-MCP200     Document Type: Article

References (50)

1. MacBeath, G., and Schreiber, S. L. (2000) Printing proteins as microarrays for high-throughput function determination. Science 289, 1760-1763
2. Haab, B. B., Dunham, M. J., and Brown, P. O. (2001) Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol. 2, RESEARCH0004
3. Hudelist, G., Pacher-Zavisin, M., Singer, C. F., Holper, T., Kubista, E., Schreiber, M., Manavi, M., Bilban, M., and Czerwenka, K. (2004) Use of high-throughput protein array for profiling of differentially expressed proteins in normal and malignant breast tissue. Breast Cancer Res. Treat. 86, 281-291
4. Haab, B. B. (2005) Antibody arrays in cancer research. Mol. Cell. Proteomics 4, 377-383
5. Orchekowski, R., Hamelinck, D., Li, L., Gliwa, E., vanBrocklin, M., Marrero, J. A., Vande Woude, G. F., Fang, Z., Brand, R., and Haab, B. B. (2005) Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer. Cancer Res. 65, 11193-11202
6. Ellmark, P., Ingvarsson, J., Carlsson, A., Lundin, B. S., Wingren, C., and Borrebaeck, C. A. K. (2006) Identification of protein expression signatures associated with Helicobacter pylori infection and gastric adenocarcinoma using recombinant antibody microarrays. Mol. Cell. Proteomics 5, 1638-1646
7. Borrebaeck, C. A. K., and Wingren, C. (2007) High-throughput proteomics using antibody microarrays: an update. Expert Rev. Mol. Diagn. 7, 673-686
8. Olle, E. W., Sreekumar, A., Warner, R. L., McClintock, S. D., Chinnaiyan, A. M., Bleavins, M. R., Anderson, T. D., and Johnson, K. J. (2005) Development of an internally controlled antibody microarray. Mol. Cell. Proteomics 4, 1664-1672
9. Hamelinck, D., Zhou, H., Li, L., Verweij, C., Dillon, D., Fang, Z., Costa, J., and Haab, B. B. (2005) Optimized normalization for antibody microarrays, and application to serum-protein profiling. Mol. Cell. Proteomics 4, 773-784
10. Lin, Y., Huang, R., Santanam, N., Liu, Y., Parthasarathy, S., and Huang, R. (2002) Profiling of human cytokines in healthy individuals with vitamin E supplementation by antibody array. Cancer Lett. 187, 17-24
11. Campbell, C. T., and Kim, G. (2007) SPR microscopy and its applications to high-throughput analyses of biomolecular binding events and their kinetics. Biomaterials 28, 2380-2392
12. Boozer, C., Kim, G., Gong, S., Guan, H., and Londergan, T. (2006) Looking towards label-free biomolecular interaction analysis in a high-throughput format: a review of new surface plasmon resonance technologies. Curr. Opin. Biotechnol. 17, 400-405
13. Wegner, G. J., Lee, H. J., and Corn, R. M. (2002) Characterization and optimization of peptide arrays for the study of epitope-antibody interactions using surface plasmon resonance imaging. Anal. Chem. 74, 5161-5168
14. Smith, E. A., and Corn, R. M. (2003) Surface plasmon resonance imaging as a tool to monitor biomolecular interactions in an array based format. Appl. Spectrosc. 57, 320-332
15. Smith, E. A., Thomas, W. D., Kiessling, L. L., and Corn, R. M. (2003) Surface plasmon resonance imaging studies of protein-carbohydrate interactions. J. Am. Chem. Soc. 125, 6140-6148
16. Fang, S., Lee, H. J., Wark, A. W., Kim, H. M., and Corn, R. M. (2005) Determination of ribonuclease H surface enzyme kinetics by surface plasmon resonance imaging and surface plasmon fluorescence spectroscopy. Anal. Chem. 77, 6528-6534
17. Wark, A. W., Lee, H. J., and Corn, R. M. (2005) Long-range surface plasmon resonance imaging for bioaffinity sensors. Anal. Chem. 77, 3904-3907
18. Chou, S., Hsu, W., Hwang, J., and Chen, C. (2004) Development of an immunosensor for human ferritin, a nonspecific tumor marker, based on surface plasmon resonance. Biosens. Bioelectron. 19, 999-1005
19. Usui-Aoki, K., Shimada, K., Nagano, M., Kawai, M., and Koga, H. (2005) A novel approach to protein expression profiling using antibody microarrays combined with surface plasmon resonance technology. Proteomics 5, 2396-2401
20. de Boer, A. R., Hokke, C. H., Deelder, A. M., and Wuhrer, M. (2008) Serum antibody screening by surface plasmon resonance using a natural glycan microarray. Glycoconj. J. 25, 75-84
21. Anderson, N. L., and Anderson, N. G. (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 1, 845-867
22. Fujiyama, S., Tanaka, M., Maeda, S., Ashihara, H., Hirata, R., and Tornita, K. (2002) Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma. Oncology 62, Suppl. 1, 57-63
23. Myszka, D. G., and Morton, T. A. (1998) CLAMP: a biosensor kinetic data analysis program. Trends Biochem. Sci. 23, 149-150
24. Fivash, M., Towler, E. M., and Fisher, R. J. (1998) BIAcore for macromolecular interaction. Curr. Opin. Biotechnol. 9, 97-101
25. Edwards, P. R., Gill, A., Pollard-Knight, D. V., Hoare, M., Buckle, P. E., Lowe, P. A., and Leatherbarrow, R. J. (1995) Kinetics of protein-protein interactions at the surface of an optical biosensor. Anal. Biochem. 231, 210-217
26. Karlsson, K, and Aryasetiawan, F. (1995) Plasmon lifetime, zone-boundary collective states, and energy-loss spectra of lithium. Phys. Rev. B Condens. Matter 52, 4823-4827
27. Kojima, K., Mihara, R., Sakai, T., Togari, A., Matsui, T., Shinpo, K., Fujita, K., Fukasawa, K., Harada, M., and Nagatsu, T. (1987) Serum activities of dipeptidyl-aminopeptidase II and dipeptidyl-aminopeptidase IV in tumor-bearing animals and in cancer patients. Biochem. Med. Metab. Biol. 37, 35-41
28. Chang, W. Y., and Chuang, W. L. (1988) Complements as new diagnostic tools of hepatocellular carcinoma in cirrhotic patients. Cancer 62, 227-232
29. Ataseven, H., Bahcecioglu, I. H., Kuzu, N., Yalniz, M., Gelebi, S., Erensoy, A., and Ustundag, B. (2006) The levels of ghrelin, leptin, TNF-α, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection. Mediat. Inflamm. 2006, 1-6
30. Zaloudik, J., Lauerova, L., Janakova, L., Talac, R., Simickova, M., Nekulova, M., Mikulikova, I., Kovarik, J., and Sheard, M. (1999) Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver. Hepatogastroenterology 46, 220-227
31. Chau, G. Y., Wu, C. W., Lui, W. Y., Chang, T. J., Kao, H. L., Wu, L. H., King, K. L., Loong, C. C., Hsia, C. Y., and Chi, C. W. (2000) Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma. Ann. Surg. 231, 552-558
32. Minagawa, H., Honda, M., Miyazaki, K., Tabuse, Y., Teramoto, R., Yamashita, T., Nishino, R., Takatori, H., Ueda, T., Karnijo, K., and Kaneko, S. (2008) Comparative proteomic and transcriptomic profiling of the human hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 366, 186-192
33. Lee, I., Chen, C., Sheu, J., Lee, H., Huang, G., Yu, C., Lu, F., and Chow, L. (2005) Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry. J. Proteome Res. 4, 2062-2069
34. Pérez-Saborido, B., de los Galanes, S. J., Mendu-Díaz, J. C., Romero, C. J., Elola-Olaso, A. M., Suárez, Y. F., Valencia, V. B., and Moreno-González, E. (2007) Tumor recurrence after liver transplantation for hepatocellular carcinoma: recurrence pathway and prognostic factors. Transplant. Proc. 39, 2304-2307
35. Chen, X., Cheung, S. T., So, S., Fan, S. T., Barry, C., Higgins, J., Lai, K., Ji, J., Dudoit, S., Ng, I. O. L., Van De Rijn, M., Botstein, D., and Brown, P. O. (2002) Gene expression patterns in human liver cancers. Mol. Biol. Cell 113, 1929-1939
36. Xu, X. R., Huang, J., Xu, Z. G., Qian, B. Z., Zhu, Z. D., Yan, Q., Gai, T., Zhang, X., Xiao, H. S., Qu, J., Liu, F., Huang, Q. H., Cheng, Z. H., Li, N. G., Du, J. J., Hu, W., Shen, K. T., Lu, G., Fu, G., Zhong, M., Xu, S. H., Gu, W. Y., Huang, W., Zhao, X. T., Hu, G. X., Gu, J. R., Chen, Z., and Han, Z. G. (2001) Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc. Natl. Acad. Sci. U. S. A. 98, 15089-15094
37. Yang, F. M., Friedrichs, W. E., Buchanan, J. M., Herbert, D. C., Weaker, F. J., Brock, J. H., and Bowman, B. H. (1990) Tissue specific expression of mouse transferrin during development and aging. Mech. Ageing Dev. 56, 187-197
38. Peters, T. (1995) All about Albumin: Biochemistry, Genetics, and Medical Applications, pp. 228-233, Academic Press, New York
39. Moody, M. D., Van Arsdell, S. W., Murphy, K. P., Orencole, S. F., and Burns, C. (2001) Array-based ELISAs for high-throughput analysis of human cytokines. Bio Techniques 31, 186-190, 192-194
40. Mendoza, L. G., McQuary, P., Mongan, A., Gangadharan, R., Brignac, S., and Eggers, M. (1999) High-throughput microarray-based enzyme-linked immunosorbent assay (EUSA). BioTechniques 27, 778-780, 782-786, 788
41. Meyer, M. H. F., Hartmann, M., and Keusgen, M. (2006) SPR-based immunosensor for the CRP detection - a new method to detect a well known protein. Biosens. Bioelectron. 21, 1987-1990
42. Asgeirsson, K. S., Agrawal, A., Allen, C., Hitch, A., Ellis, I. O., Chapman, C., Cheung, K. L., and Robertson, J. F. (2007) Serum epidermal growth factor receptor and HER2 expression in primary and metastatic breast cancer patients. Breast Cancer Res. 9, R75
43. Baron-Hay, S., Boyle, F., Ferrier, A., and Scott, C. (2004) Elevated serum insulin-like growth factor binding protein-2 as a prognostic marker in patients with ovarian cancer. Clin. Cancer Res. 10, 1796-1806
44. Wang, C. S., Wu, T. L., Tsao, K. C., and Sun, C. F. (2006) Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker. Ann. Clin. Lab. Sci. 36, 23-30
45. Wu, C. Y., Wu, M. S., Chiang, E. P., Chen, Y. J., Chen, C. J., Chi, N. H., Shih, Y. T., Chen, G. H., and Lin, J. T. (2007) Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution. Clin. Cancer Res. 13, 2054-2060
46. Kim, J. H., Skates, S. J., Uede, T., Wong, K. K., Schorge, J. O., Feltmate, C. M., Berkowitz, R. S., Cramer, D. W., and Mok, S. C. (2002) Osteopontin as a potential diagnostic biomarker for ovarian cancer. J. Am. Med. Assoc. 287, 1671-1679
47. Kitahara, F., Kobayashi, K., Sato, T., Kojima, Y., Araki, T., and Fujino, M. A. (1999) Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut 44, 693-697
48. Tsukishiro, S., Suzumori, N., Nishikawa, H., Arakawa, A., and Suzumori, K. (2006) Elevated serum RANTES levels in patients with ovarian cancer correlate with the extent of the disorder. Gynecol. Oncol. 102, 542-545
49. Wiebe, E., Rodrigues, G., Lock, M., D'Souza, D., and Stitt, L. (2008) Outcome analysis of prostate cancer patients with pre-treatment PSA greater than 50 ng/ml. Can. J. Urol. 15, 4078-4083
50. Goldstein, M. J., and Mitchell, E. P. (2005) Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Investig. 23, 338-351